Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-14

FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Trifluent Pharma, LLC)

View source ↗

Summary

FDA approved a generic dicyclomine hydrochloride product from Trifluent Pharma, LLC via its Original Application (ANDA 216736).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dicyclomine hydrochloride (Dicyclomine hydrochloride)

Snippet

ORIG AP for DICYCLOMINE HYDROCHLORIDE (DICYCLOMINE HYDROCHLORIDE)